NasdaqCM - Delayed Quote • USD
Regulus Therapeutics Inc. (RGLS)
At close: 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AKER CHRISTOPHER RAY General Counsel | Sale | Jan 18, 2024 | 10,056 |
| BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2020 | -- |
| CALSADA CRISPINA CPA Chief Financial Officer | Sale | Jan 18, 2024 | 5,782 |
| DRYGIN DENIS Officer | Purchase | Mar 1, 2022 | 100,000 |
| FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2020 | -- |
| HAGAN JOSEPH PATRICK Chief Executive Officer | Sale | Jan 18, 2024 | 57,112 |
| MAKOWER JOSHUA Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2020 | -- |
| PAPADOPOULOS STELIOS B Director | Stock Award(Grant) | Mar 14, 2024 | 978,388 |
| SONSINI PETER W Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2020 | -- |
| WALKER PAUL EDWARD Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 4, 2020 | -- |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
3.4650
+1.61%
PEPG PepGen Inc.
10.54
-11.06%
CERO CERo Therapeutics Holdings, Inc.
1.5000
-2.60%
CLRB Cellectar Biosciences, Inc.
3.0300
-0.33%
ELEV Elevation Oncology, Inc.
3.8000
-5.24%
IMRN Immuron Limited
2.3100
-5.71%
XLO Xilio Therapeutics, Inc.
1.1500
-10.16%
NKGN NKGen Biotech, Inc.
1.1060
+28.60%
EQ Equillium, Inc.
1.6100
-6.94%
TRVI Trevi Therapeutics, Inc.
2.8350
+5.59%